Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies.

Hakomäki H, Pitkänen S, Levonen AL, Honkakoski P, Greco D, D'Alessandro N, Saarimäki LA, Viegas S, Godinho C, Fyhrquist N, Wincent E, Lauschke VM, Hukkanen J, Hakkola J, Vallier L, Fortino V, Afantitis A, Sawatani T, Guzman TJ, Cnop M, Nawrot T, Harlid S, Vinnars MT, Tardon A, Grimalt JO, Küblbeck J, Rysä J

Open source

DOI: 10.12688/openreseurope.18439.2
Published: 2024
Container: Open research Europe
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.12688/openreseurope.18439.2,
  title = {Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies.},
  author = {Hakomäki H and Pitkänen S and Levonen AL and Honkakoski P and Greco D and D'Alessandro N and Saarimäki LA and Viegas S and Godinho C and Fyhrquist N and Wincent E and Lauschke VM and Hukkanen J and Hakkola J and Vallier L and Fortino V and Afantitis A and Sawatani T and Guzman TJ and Cnop M and Nawrot T and Harlid S and Vinnars MT and Tardon A and Grimalt JO and Küblbeck J and Rysä J},
  year = {2024},
  journal = {Open research Europe},
  doi = {10.12688/openreseurope.18439.2},
  url = {https://doi.org/10.12688/openreseurope.18439.2}
}

RIS

TY  - JOUR
TI  - Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies.
AU  - Hakomäki H
AU  - Pitkänen S
AU  - Levonen AL
AU  - Honkakoski P
AU  - Greco D
AU  - D'Alessandro N
AU  - Saarimäki LA
AU  - Viegas S
AU  - Godinho C
AU  - Fyhrquist N
AU  - Wincent E
AU  - Lauschke VM
AU  - Hukkanen J
AU  - Hakkola J
AU  - Vallier L
AU  - Fortino V
AU  - Afantitis A
AU  - Sawatani T
AU  - Guzman TJ
AU  - Cnop M
AU  - Nawrot T
AU  - Harlid S
AU  - Vinnars MT
AU  - Tardon A
AU  - Grimalt JO
AU  - Küblbeck J
AU  - Rysä J
PY  - 2024
JO  - Open research Europe
DO  - 10.12688/openreseurope.18439.2
UR  - https://doi.org/10.12688/openreseurope.18439.2
ER  -

APA

H, H., S, P., AL, L., P, H., D, G., N, D., LA, S., S, V., C, G., N, F., E, W., VM, L., J, H., J, H., L, V., V, F., A, A., T, S., TJ, G., M, C., T, N., S, H., MT, V., A, T., JO, G., J, K., & J, R. (2024). Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies.. Open research Europe. https://doi.org/10.12688/openreseurope.18439.2

Source records

pubmed · retrieved 2026-09-26T23:15:48.932Z